Figure 1From: Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience Shrinkage of peritoneal disease after 12 months of treatment with pazopanib (August 2012, A; July 2013, B) in a 30 years old man, PS:0, affected by widespread intrabdominal DSRCT with liver and soft tissue metastases. Back to article page